Treatment of Multiple Sclerosis With Natalizumab in Routine Practice
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Scientific Reports
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years
Sci Rep 2021 Dec 02;11(1)23317, M Auer, A Zinganell, H Hegen, G Bsteh, F Di Pauli, K Berek, E Fava, S Wurth, T Berger, F DeisenhammerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.